Correlation Between Quoin Pharmaceuticals and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Lipella Pharmaceuticals.
Diversification Opportunities for Quoin Pharmaceuticals and Lipella Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Quoin and Lipella is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Lipella Pharmaceuticals
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 2.48 times less risky than Lipella Pharmaceuticals. The stock trades about -0.28 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 285.00 in Lipella Pharmaceuticals Common on November 18, 2024 and sell it today you would earn a total of 103.00 from holding Lipella Pharmaceuticals Common or generate 36.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| Lipella Pharmaceuticals |
Quoin Pharmaceuticals and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and Lipella Pharmaceuticals
The main advantage of trading using opposite Quoin Pharmaceuticals and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |